Recombination activating genes 1 and 2 (RAG-1 and RAG-2). are the only lymphoid-specific genes required for the sitedirected recombination reaction leading to generation of Bcell receptors and T-cell receptors (TCRs). RAGS are normally expressed during a narrow window of precursor lymphocyte development. RAG expression was examined in Epstein-Barr virus (EBV)-infected B cells. No steady-state RAG RNA was found in EBV immortalized cells, including newly established B lymphoblastoid cell lines derived from precursor lymphocytes that transcribed RAGS at the time of infection. RAG RNAs were detected in some endemic (EBV') and also in some sporadic (EBV-) Burkitt's lymphoma lines that had been infected with EBV in vitro. The RAG+, EBV+ Burkitt's lines were unusual in that they were SIgM+ (one was SIgG', PSTEIN-BARR virus (EBV) was discovered 30 years ago in tissue from patients with African Burkitt's lymphoma.' Although in vitro EBV efficiently immortalizes only normal B lymphocytes, the viral genome has been identified in a variety of B and T lymphoid, histiocytoid, and epithelial neoplasms.' African Burkitt's lymphoma is the most common childhood tumor in endemic regions that are characterized by proximity to the equator and a high incidence of malaria. The short latency period between viral infection and malignancy, coupled with the observation that virtually all of these tumors contain EBV genomes, suggests virus contributes to early tumorigenic events.'
PSTEIN-BARR virus (EBV) was discovered 30 years
ago in tissue from patients with African Burkitt's lymphoma.' Although in vitro EBV efficiently immortalizes only normal B lymphocytes, the viral genome has been identified in a variety of B and T lymphoid, histiocytoid, and epithelial neoplasms.' African Burkitt's lymphoma is the most common childhood tumor in endemic regions that are characterized by proximity to the equator and a high incidence of malaria. The short latency period between viral infection and malignancy, coupled with the observation that virtually all of these tumors contain EBV genomes, suggests virus contributes to early tumorigenic events. ' In normal B cells immortalized by EBV in vitro (referred to as lymphoblastoid cell lines [LCLs] ), at least 11 latent viral genes encoding six nuclear proteins (EBNA-l, -LP, -2, -3A, -3B, and -3C), three membrane proteins (latent membrane protein [LMPI-1, -2A, and -2B), and two small, nonpolyadenylated RNAs (EBER 1 and 2) are regularly tran~cribed.~.' Molecular genetic analyses indicate that the EBNA-I, -LP, -2, -3A, and -3C and the membrane protein LMP-l are absolutely required for immortalization. 6 The role(s) of the respective proteins in initiation and maintenance of the transformed state are variably understood. EBNA-1 regulates replication of the EBV plasmid and is a transcriptional transactivator of additional viral gene^.^,^,'"
The remaining nuclear proteins are believed to function in regulating viral and/or growth regulatory gene^.^.','^," LMP-1 promotes transformation of rodent fibroblasts,".'3 inhibits epithelial differentiati~n,'~ upregulates cellular activation-associated antigensIs (ie, CD21, CD23, CD40, CD54, LFA-l, LFA-3, and others), and downmodulates specific cellular genes, including CD10, CD77, insulin-like growth factor receptor type l , and E-~adherin.'~"~ Studies indicate that LMP-l transduces a signal that results in the activation of nuclear factor kappa B (NFKB)-responsive elements.'8. '9 In contrast to LCLs, viral gene expression in endemic lymphomas is more variable. With the exception of EBNA-1, required for episomal replication of the virus, transcription of latent genes may be undetectable." Variable expression of LMP-1 has been observed among the respective Burkitt's lymphoma lines, although, within a given Burkitt's cell line, the level of LMP-1 expression appears to be very consistent." All Burkitt's lymphomas contain an 8/14 or related vidual proteins that participate in this reaction are largely unknown. Two closely linked genes, RAG-l and RAG-2,28.29 that together are both necessary and sufficient to mediate V(D)J recombination of an artificial substrate after transfer into nonlymphoid cells have been identified. These genes are coordinately expressed during a narrow window of precursor lymphocyte development which in B lymphocytes spans the late pro-B-cell through early immature B-cell stages. RAG-1 and RAG-2 are highly conserved during vertebrate evolution,*' and gennline deletion of either gene in mice abrogates lymphocyte maturation.'".'' A third lymphoid-specific protein, terminal deoxynucleotidyl transferase (TdT), is expressed early in development and also participates in V(D)J recombination through addition of nucleotides to the coding joint that is normally formed. However, TdT is not strictly required for this site-directed recombination reaction."
The observations that translocations involving V(D)J loci occur in EBV' Burkitt's lymphomas and that structural elements associated with recombinase activity have been identified at some chromosomal breakpoints from these tumors prompted us to examine whether RAG-l and RAG-2 were transcribed in EBV-immortalized lymphocytes and EBV' tumor lines. We report that RAG gene transcripts can be detected in several virus-infected Burkitt's lymphoma lines. Evaluation of these lines suggests that the presence of virus Single-cell suspensions from fetal liver, spleen, and thymus were prepared by mincing the tissue through wire mesh. The cells were then processed as described above.
Virus pur$cation and establishment of immortalized cell lines. Marmoset cells immortalized with the prototype B95-8 strain of EBV (ATCC) were suspended at 5 X 10' to 1 X 10' cells per milliliter and grown for 5 days. The cells were centrifuged at 400g for I O minutes, and the supernatant was poured through a 0.22-pm filter (Nalgene, Rochester, NY). The virus-containing supematant was directly incubated with lymphocytes at IO3 to 10' cells per milliliter for 2 hours at 37"C, washed once, and resuspended in media at a concentration appropriate to each experiment.
Antibodies Iwn specificities were used as isotype-matched controls for the 'I : I 7 bodies enumerated above. Antibodies were used at a concentrat) . , I of approximately 10 to 40 pg/ mL determined to be approximately 10-fold in excess of saturation based on cytometric analysis of standard cell lines. For detection, fluorescein isothiocyanate (FITC)-labeled goat F(ab')* antimouse IgG or, in some cases, antimouse IgGAM (Tagoimmunologicals, Camarillo, CA) at a concentration of 10 pg/mL was used. For analysis of Ig light chains, affinity-isolated FITC-labeled goat F(ab')* anti-human lambda light chain and anti-human kappa light chain antibodies were used (Tagoimmunologicals) with preimmune goat FITC-labeled F(ab' ), (Tagoimmunologicals) as a control.
Probes. The following DNAs were used as probes. Human Cp and JH,34 CA," and C K~' genomic clones were provided by Philip Leder, Harvard University. Human RAG-l cDNA(H36)" was provided by Marjorie Oettinger, Massachusetts General Hospital, Boston, MA. A 707-bp EcoRI subfragment of human RAG-l was used as a probe. The size of RAG-l RNA detected was 6.6 kb. RAG-2 CDNA'' was provided by Craig Thompson, University of Michigan Medical Center, Ann Arbor, MI. An approximately 650-bp Not ISal I subfragment of human RAG-2 was used as a probe. The size of the major RAG-2 RNA was 2.2 kb, with additional species detected. Human CD10 cDNA'~ was provided by Margaret Shipp, DanaFarber Cancer Institute. A 1,587-bp subfragment of human CD10 was used as a probe. The size of the major CD10 RNAs were 5. DNA blot hybridization. Genomic DNA was prepared from tissue culture cells as de~cribed.~' For analysis of Ig gene rearrangements, DNA was cut with the indicated restriction enzymes, and DNA blot hybridization was performed with the specified probes as described."' RNA blot hybridization. RNA was prepared using the method of Chomczynski and Sacchi" and quantitated by absorbance at 260 nm. Total RNA, 15 pg per lane, was subjected to electrophoresis through a 1% agarose gel containing 2.2 molL formaldehyde and blotted onto NitroPlus transfer membranes (MSI, Westboro, MA) as de~cribed.~' The RNA was fixed to the membrane using ultraviolet light applied with the Stratalinker 2400 (Stratagene, La Jolla, CA) at 120 mJ for 60 seconds to the RNA side of the membrane. Prehybridization, hybridization (approximately 10' cpm of specific probe per milliliter), and washing was performed as described." Two or more final washes were performed with 0.2 X standard sodium citrate (SSC), 0.1% sodium dodecyl sulfate (SDS) at 60°C to 65°C for 30 and then 20 minutes. The membrane was air-dried and exposed to XAR-5 film (Kodak, Rochester, NY) with an intensifying screen at -70°C for 1 to I O days.
RESULTS

Endemic Burkitt's lymphomas express RAG-1 and RAG-2.
EBV-infected cells have not been reported to express RAG demic Burkitt's lymphoma liness8 were examined for RAG gene expression, RAG-l RNA was detected in three of these lines: Akata, Daudi, and Namalwa (Fig 1, A and B) . RAG-l RNA was not detected in P3HR1, MABA, or Raji (Fig 1, C  and D) . Namalwa has been reported to lack RAG transcripts; however, the cell line has been in culture for many years, and several independent sources are a~ailable.'~ Namalwa cells obtained from the ATCC expressed both RAG-l and RAG-2 (Fig l , C and D) . Transcription of RAG-l in the central nervous system has been detected in the absence of RAG-260; however, all lymphocyte populations thus far studied transcribe both genes. In the EBV+ Burkitt's lymphoma lines, transcription of RAG-l was always accompanied by RAG-2 (Fig 1, C and  D, and Fig 2) . A single RAG-l mRNA of approximately 6.6 kb was detected, whereas a major RAG-2 transcript of approximately 2.2 kb with one or two additional species were detected genes~28.s~sl However, when several well-characterized enFor personal use only. on October 27, 2017. by guest www.bloodjournal.org From (Figs 1 and 2) . This was similar to control B-lymphoblastic leukemia cell lines (Fig 2) and to normal fetal B cells (Fig 3) .
Developmerltcrl chorcrcterizcrtior1 (Fig 2) and CDIO'"-5" (Fig 3) . RAG 
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B-lineage cells were obtained primarily from bone marrow (femur), but also from liver, spleen, and thymus of SO fetuses aged I I to 22 weeks and incubated with ERV. Twenty stably immortalized fetal lines established from 14 to 22-week fetal lymphocytes were further characterized. Predominantly monoclonal, but also some polyclonal, populations were obtained. The surface phenotype of a l l the fetal lymphoblastoid cells was identical to that of lines established from cord or peripheral adult blood (ie, CD1 la', CD19'. CD20'. CD21'. CD23', B7', CD30', CD39', CD40'. CDS4', CDS8'. CD34 , CDIO-, CD77 ; data not shown) and resembled activated mature B cells. In some cases, however, no Ig was present on the cell surface, while in others, heavy chain alone could be detected. The majority of LCLs were SlgM' with a lambdxkappa ratio of approximately I : I , reflecting the surface Ig composition of normal fetal tissue. These results were in agreement with recent descriptions of pro-. pre-, and immature B cells transformed by EBV.s".f"-6x The state of Ig gene rearrangement in the respective lines was confirmed by DNA blot hybridization (data not shown).
RAG-1 and RAG-2 RNA expression by three newly established fetal LCLs (4 to 6 weeks after incubation with virus) was first compared with expression by the established peripheral blood cell line SB"" and a newly established cord blood cell line, Cord A (Fig 3, A through D) . No RAG-l or RAG-2 RNA was detected in any of the EBV-transformed cells, including fetus L(p+, X+), fetus M(p-~-h-) and fetus F(p+, K + ) (Fig 3, A through D) . CDIO RNA, which is normally expressed in fetal B cells and Burkitt's lymphom a~,~" but which is downmodulated by LMP-I was not detected in any of these lines (Fig 3, A through D) . As expected, a B-acute lymphoblastic leukemia line, Nalm-6.7' expressed all three RNAs.
When purified fetal B lymphocytes used to establish immortalized lines were evaluated, RAG transcripts were readily detected (Fig 3, E through G) , demonstrating that at the time EBV was added, fetal lymphocytes transcribed RAG-l and RAG-2. Interestingly, while RAG RNAs were been described.sas6 As with virtually all Burkitt's lymphomas,"' the RAG' Burkitt's lines were CDIO' (data not shown). However, unlike the ALL cell lines, none of the RAG' endemic lymphoma lines expressed TdT RNA (Fig 2 and data not  shown) .
EUV immortalized cells established from fetcrl U Ivnlphocytes, which actively transcribe RAG-l and RAG-2, c/o not express RAG RNA. Because most LCLs originate from cord or adult peripheral blood, transcription of RAG genes would predictably be absent in these populations. In addition, many EBV' lines had been in culture for long periods, raising the possibility that transcription of RAG genes could cease upon prolonged passage, as has been observed in murine B-cell lines."' Based on the findings in the endemic lymphoma lines and also on the observation that murine B cells immortalized with Abelson leukemia virus frequently expressed RAG established to determine whether RAG transcripts could be detected. always detected in lymphocytes from fetal bone marrow (Fig 3, E and F) , spleen, and thymus (data not shown), transcription in liver was more variable, often equal to (Fig  3, H and I ) but sometimes less than (Fig 3, E through G) RNAs detected in other lymphoid populations from the same fetus. In the latter case, the hepatic lymphocytes were less mature (predominantly early pro-B cells based on absence of B-and pre-B-cell surface markers; data not shown). RAG RNAs were not detected in mature lymphocyte populations (Fig 3, E through G) .
When fetal B cells were placed in culture without EBV, RAG gene expression diminished over I week (Fig 3, H and  I) , as many fetal cells died and others presumably differentiated? Virtually no RAG transcripts could be detected 4 days after EBV was added. However, because of substantial RNA degradation, particularly in the presence of virus, it was not possible to conclusively demonstrate that virus accelerated downmodulation of RAG genes in cultured B cells. In one fetal cell line (F IIN LCL), which grew out from bone marrow lymphocytes less than 2 weeks after incubation with EBV, no RAG-l or RAG-2 RNA could be detected (Fig 3,  H and I) . None of the newly established fetal cell lines expressed RAG-1, RAG-2, or CD 10 RNA (Fig 3) . TdT was also absent from all lines studied (data not shown). Sporodic Burkitt's lvmphomns do not express R A G I or RAG-2, but may transcribe these genes qjier EBV infection. Sporadic Burkitt's lymphomas are morphologically similar to endemic tumors: however, they differ in some salient aspects. They occur worldwide, uncommonly contain EBV DNA (approximately 15% to 20%). vary in tissue distribution, peak at a later age, and can be distinguished on a molecular genetic basis.'.'' Virtually all Burkitt's lymphomas contain an 8/14 or related chromosomal translocation..'.'? In endemic Burkitt's lymphomas, the c-myc protooncogene is often juxtaposed to the region of the Ig heavy chain locus transcribed during the V(D)J recombination process.'.'." Heptamer-nonamer signal sequences that serve to target gene segments for V(D)J recombination have sometimes been identified in the vicinity of these breakpoints." In sporadic Burkitt's lymphomas, c-my is more frequently joined to loci transcribed during switch recombination; however, these distinctions are not absolute. Furthermore, in patients infected with HIV, an increased frequency of Burkitt's lymphomas has been observed that occur sporadically, but are often EBV' and resemble endemic lymphomas. Because this has led to some confusion, in this report EBV+ will always be equated with endemic lymphomas and EBVwith sporadic lymphomas. When three EBV-, sporadic Burkitt's lymphomasRamos,N BL41," and BL307' (Fig 4) -were analyzed, no RAG-I or RAG-2 RNA was detected, nor were these genes detected in one EBV-Burkitt's-like lymphoma, BJAB.-These data are consistent with the proposal that sporadic lymphomas arise from mature B cells at rest before switch recombination, a stage at which RAG genes are silent. Somewhat unexpectedly, when the sporadic Burkitt's lines that had been infected with EBV in vitro were assessed, RAG gene transcription was observed in several infected lines (Figs 2 and 5 ; E through H). Each of the four sporadic Burkitt's lines had been infected in vitro either with transforming virus B958 or with the nontransforming strain P3HR1,74 giving rise to sets of three: ie, BL4l (parent), BL4IIP3, and BL41/B95 (see Materials and Methods). These sets have been used extensively to characterize EBV-induced gene expression. The P3HRI strain is deleted in the EBNA-2EBNA-LP viral transactivation genes required for immortalization, but can stably infect the tumor lines because they do not require virus for growth. The EBV' sporadic Burkitt's lines BL4IP3 (Fig 5) and BL30/P3 (Figs 2 and 5) and also BL30/B958 (Figs 2 and 6 ) expressed RAG-I and RAG-2, whereas others (BL41B958, RamodB958, RamosIP3, BJAB/B958, and BJABP3) did not (Fig 5, Table l ) . Similar to other lymphoid cells, RAG-l and RAG-2 expression was coordinate (data not shown). The EBV', RAG' sporadic lines were SIgM'7s (data not shown), CDIO' (data not shown), and TdT- (Fig 2 and data not shown) , similar to RAG' endemic lymphomas.
EBV' Burkitt's lymphomas that express LMP-I downmoduhte RAG-l and RAG-2. The complex pattern of RAG gene expression in EBV-infected B cells raised the possibility that RAG genes might be regulated by a viral product. Whereas RAG-l and RAG-2 expression in endemic and particularly in EBV-infected sporadic Burkitt's lymphoma lines suggested an association with virus, the absence of RAG transcripts in fetal LCLs and in some EBV' Burkitt's lymphomas suggested that a viral gene product(s) that was consistently expressed in LCLs but variably expressed in Burkitt's lymphomas might negatively regulate RAG RNAs. Prior studies had shown that, in EBV' Burkitt's lymphoma, transcription of viral lytic genes was rare and that transcription of latency associated genes, except for EBNA-I, was variable and frequently absent." Evaluation of latent RNAs
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From in the endemic Burkitt's lymphomas and also in the infected sporadic Burkitt's lymphomas that did and that did not express RAG genes showed an association between expression of LMP-1 and the absence of RAG-l and RAG-2 RNAs (Fig 5 , Table l) , with the possible exception of BL3043958 (Fig 6) .
Cloning of Burkitt's lymphoma cell lines confirms the inverse relationship between RAG gene and LMP-I expression. In initial studies BL30B958 appeared to express both RAG genes and LMP-1 (Fig 6, A through C) , albeit at low levels. As many of the Burkitt's lines had been in continuous culture, it was possible that variation had developed among individual cells. Thus, to more precisely define the relationship between viral and RAG gene expression, BL30IB958 was cloned by limiting dilution. The derived clones all expressed RAG-l, and no LMP-I could be detected (Fig 6, A  through C) . When Daudi Burkitt's lymphoma cells were similarly cloned, comparison of five newly derived clones demonstrated a reciprocal relationship between the level of LMP-1 and RAG-l steady-state RNA expression (Fig 6, D  through F) that was similar to that reported for CD10 and LMP-1. Five clones from the Namalwa line all expressed LMP-1, and no RAG-l or RAG-2 RNA was detected in these clones (data not shown).
When the IO remaining latency-associated transcripts were assessed, no EBV genes other than LMP-I correlated with absence of RAG RNAs. However, a role for additional EBV genes cannot be absolutely excluded. In particular, the reciprocal pattern of RAG/LMP-l expression in the naturally occurring mutant tumor lines [ie, P3HR-I, Daudi. and Namalwa ( Table 1 ) deleted in EBNA-2EBNA-LP (P3HR-I and Daudi) and in LMP-2 (Namalwa)] suggested that negative regulation by these genes independent of effects on LMP-I was unlikely. Transcription of EBNA-3 genes in the Burkitt's lines was variable and did not correlate with absence of RAG gene expression (data not shown). The EBV' cell lines, irrespective of RAG expression, transcribed the EBNA-I protein4.' (data not shown).
DISCUSSION
These experiments show that the lymphoid-specific genes RAG-l and RAG-2 may be expressed in B cells infected with EBV. RAG transcripts were readily detected in three of seven endemic (EBV') Burkitt's lymphoma cell lines. Developmental analysis showed that these Burkitt's lines were more mature than previously characterized RAG' human B cells, as they were uniformly SIg' and TdT . The importance of TdT for normal execution of the V(D)J recombination reaction in vivo is not fully defined.
In mice, a subgroup of Eu-myc transgenic B-cell tumors as well as small populations of normal B cells in bone marrow and neonatal spleen have been found to coexpress RAG genes and SIgM. Preliminary experiments in the laboratory indicate that this population is also present in human fetal B cells, which suggests that RAG' endemic Burkitt's lymphoma lines represent the counterpart of a normal human B-cell population.
Interestingly, the RAG' endemic Burkitt's lymphoma line, Akata, was SIgG', SIgM-, indicating that switch recombination had occurred. This finding was unusual because RAG RNAs have not been detected at this late stage of maturation.s4~sh The possibility that RAG genes might be expressed transiently during B-cell ontogeny (ie, during switching or during DNA repair) has often been raised, but has never, in fact, been demonstrated. Detection of RAG RNAs in Akata thus raised the possibility that prolongation or de novo induction of RAG genes might in some way relate to EBV infection. This was supported by the further observation that among well-characterized RAG-sporadic Burkitt's lines, RAG RNAs were sometimes detected after in vitro infection with EBV. These findings raise the possibility that virus may alter the developmental window during which RAG genes can be expressed. Because EBV efficiently immortalizes mature and immature B cells, the increased frequency of myc translocations that appear to be related to the RAG gene-dependent recombinase is unexplained. Evidence has recently been presented which shows that virus can infect cells that have already developed the characteristic myc translo~ation.'~ Although we have not demonstrated functional recombinase activity, the current findings raise the possibility that EBV may contribute more directly to aberrant recombination by supporting or inducing RAG transcripts in certain cellular environments.
Because RAG RNAs could be detected in several EBV+ Previous studies showed that LMP-1, a viral membrane protein required for imm~rtalization$~.~~ was able to downmodulate expression of CD10. As with RAG-I and RAG-2, CD10 RNA was detected in fetal B cells before but not after EBV immortalization. Not only the presence but the level of LMP-1 RNA was shown to be important in eliciting effective downmodulation of CDIO,l5 and this was similarly observed when single clones from the Daudi lymphoma line were studied. Clones derived from additional EBV', RAG' Burkitt's lines have further confirmed this relationship. Because LMP-I is required for immortalization of B cells, no LCLs would be predicted to express RAG-l or RAG-2.
If LMP-1 is highly expressed in LCLs, how could RAG genes become expressed and putatively contribute to aberrant recombination reactions? The host factors that regulate LMP-1 expression in B cells in vivo are currently unknown. It is clear that LMP-I is often undetectable in Burkitt's lymphomas, which presumably arise from LCLs. If LMP-1 were downmodulated in vivo in immortalized B cells (ie, by unknown factors in the host microenvironment), then survival of the cell would depend on acquisition of genetic changes that independently enhanced cell growth. Recently, it has been observed that expression of LMP-I (as well as other latency-associated genes) is decreased in SCID mice that develop EBV+ B-cell tumors after injection with human LCLs.'* Study of fetal LCLs in the SCID environment might, therefore, help to clarify how RAG genes are regulated in these cells.
As previously reported, EBNA-l is detected in all EBV+ Burkitt's lymphoma line^,^^,'^ and this included the RAG+ lines. EBNA-I is a multifunctional protein that controls transcription of additional EBV gene^^,^ and is itself regulated in a complex manner in different cell lineage^^,^"-^,*' and during the viral life cycle.82 Thus, it is possible that EBNA-1 or, alternatively, an as yet undetected viral product(s), or the presence of viral DNA itself could alter RAG transcription. A preliminary report suggesting that EBNA-l augments transcription of c-myc and Ig genes," is intriguing, as enhanced transcription also characterizes exons undergoing V(D)J rec~mbination.'~ The current experiments show that the lymphoid-specific genes RAG-I and RAG-2, required for V(D)J recombination, may be expressed in EBV' Burkitt's lymphomas and demonstrate that RAG genes are differentially regulated in distinct virus-infected B cells. The extent to which RAG transcription correlates with efficient V(D)J recombinase activity in these cells is under investigation. These results establish the possibility of a link between EBV infection and the development of chromosomal translocations involving immunoglobulin VDJ loci in Burkitt's lymphomas.
